Spray Drying Technology to Be Explored for Stabilizing Peptides, Oligonucleotides, and Monoclonal Antibodies

Pharmaceutical developers working with protein formulations, nucleotide-based drugs, peptides, and poorly soluble molecules face persistent challenges in achieving efficient and scalable manufacturing processes. Recent advancements highlight spray drying as a versatile technology that addresses these issues by stabilizing complex drug molecules while optimizing production workflows. Experts are set to discuss the potential of spray drying in enhancing the stability, bioavailability, and manufacturability of various pharmaceutical compounds during an upcoming session.

The discussion will focus on the application of spray drying for a range of molecules, including peptides, oligonucleotides, small molecules, monoclonal antibodies, and nutraceuticals. Key topics will include innovations in spray drying technology, strategies for formulation development, optimization of process parameters, and scaling up production. The session will also address methods to preserve molecular integrity throughout the spray drying process and explore how in-silico tools can streamline commercialization efforts.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: October 6, 2025

Author

Mark Chiang